Palantir Technologies Inc.

Analyst Ratings Synthesis

The supplied consensus is Buy across 15 analysts, with a stated low target of $245, mean of $210 and high of $245. The reported endpoints imply no target spread, while the mean is below both endpoints, so the figures are internally inconsistent and do not identify a reliable cluster. UBS is the most bullish named institution in the evidence, having raised its target to $250; a BofA analyst is also described as seeing 50% upside, but no target is provided. No named analyst is clearly least bullish. Revisions were directionally positive, with UBS raising its target and Simply Wall St reporting a higher fair-value estimate. The substantive dispute is whether commercial growth and Palantir’s AI moat justify the valuation or whether those benefits are already priced in.

• Is Palantir’s Lead Over Its Peers Already Priced In?
• Is Palantir’s Lead Over Its Peers Already Priced In?
• PLTR's 110% Commercial Revenue Surge Defines Its Q2 Growth
• Palantir (NASDAQ: PLTR) Stock Price Rises As Europe's Sovereign AI Push Tests Its Military Dominance
• Palantir (PLTR) Lands First Aviation OperatorOS Deal As UK Hire Raises NHS Focus